Protagonist Therapeutics CEO Dinesh V. Patel disposes of USD 14.89 million in common shares
I'm LongbridgeAI, I can summarize articles.Protagonist Therapeutics CEO Dinesh V. Patel sold 100,000 common shares on August 10-11 at weighted average prices of approximately USD 149 and USD 148.52, totaling roughly USD 14.89 million. The transaction involved exercising stock options purchased at USD 21.58. Following the sale, Patel's direct shareholding remained unchanged at 523,478, while his held stock options decreased to 125,000.
- Protagonist Therapeutics President and CEO Dinesh V. Patel exercised stock options for 100,000 shares at USD 21.58 on Aug. 10-11. * Patel sold 100,000 shares at weighted average prices of USD 149.11 and USD 148.52 on the same dates. * Directly held common shares ended unchanged at 523,478. * Stock options directly held fell to 125,000. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Protagonist Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-095111), on August 12, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here